Xuan Li

Dr. Xuan Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
YCYangkun Cao
Yangkun Cao
JXJun Xiao
Jun Xiao
NSNan Sheng
Nan Sheng
YQYinwei Qu
Yinwei Qu
ZWZhihang Wang
Zhihang Wang
XLXuan Li
Xuan Li

28 March 2025 in Biology
Verified
Journal Article
Open access
PDF file
XLXuan Li
Xuan Li
RGRenchu Guan
Renchu Guan
SZShuangquan Zhang
Shuangquan Zhang
CCA is a highly desmoplastic malignant cancer and is the second most common primary liver malignancy after hepatocellular carcinoma (HCC), accounting for approximately 15% of all primary liver tumors. CCA has a poor prognosis, with an average five-year survival rate of 9%, which is lower than that of pancreatic cancer. Although considerable efforts have been invested into the genomics, epigenetics, and risk factors, very little is known about what might have been the key causes for the high malignancy level of CCA. In this review, we analyze the incidence and mortality of CCA in different regions based on data from 1994 to 2022 obtained from the International Agency for Research on Cancer (IARC), discuss the current status of treatment of the disease, and focus on what might be the main factors contributing to the high malignancy level of CCA: alkalosis caused by the Fenton reaction, hypoxia, and the TIME. The review includes studies published from 1979 to 2024, aiming to provide an updated synthesis of basic early classical theoretical knowledge and current knowledge about CCA. By revealing the epidemiological characteristics of CCA, the potential mechanisms of high malignancy, and the current challenges of treatment, this review aims to provide new directions for future cancer research, promote the development of personalized treatment strategies, and facilitate a deeper understanding and the more effective management of CCA worldwide.

11 October 2024 in Biology
Verified
Journal Article
Open access
PDF file
XLXuan Li
Xuan Li
YWYan Wang
Yan Wang
RGRenchu Guan
Renchu Guan
NSNan Sheng
Nan Sheng
SZShuangquan Zhang
Shuangquan Zhang
Intrahepatic cholangiocarcinoma (ICC) is a highly heterogeneous malignancy. The reasons behind the global rise in the incidence of ICC remain unclear, and there exists limited knowledge regarding the immune cells within the tumor microenvironment (TME). In this study, a more comprehensive analysis of multi-omics data was performed using machine learning methods. The study found that the immunoactivity of B cells, macrophages, and T cells in the infiltrating immune cells of ICC exhibits a significantly higher level of immunoactivity in comparison to other immune cells. During the immune sensing and response, the effect of antigen-presenting cells (APCs) such as B cells and macrophages on activating NK cells was weakened, while the effect of activating T cells became stronger. Simultaneously, four distinct subpopulations, namely BLp, MacrophagesLp, BHn, and THn, have been identified from the infiltrating immune cells, and their corresponding immune-related marker genes have been identified. The immune sensing and response model of ICC has been revised and constructed based on our current comprehension. This study not only helps to deepen the understanding the heterogeneity of infiltrating immune cells in ICC, but also may provide valuable insights into the diagnosis, evaluation, treatment, and prognosis of ICC.


1 May 2025 in Journal of Computer Science and Technology
Verified
Journal Article
Closed access
PDF file
JCJiang-Nan Cui
Jiang-Nan Cui
YGYang Gao
Yang Gao
QWQiu Wang
Qiu Wang
XLXuan Li
Xuan Li
KXKe-Ren Xu
Ke-Ren Xu
CZChunman Zuo
Chunman Zuo

10 January 2025
Verified
Conference Paper
Open access
SZShuangquan Zhang
Shuangquan Zhang
JJJinxin Jia
Jinxin Jia
PGPeng Gao
Peng Gao
XLXuan Li
Xuan Li
YWYan Wang
Yan Wang